Katrin Tiemann

1.1k total citations
15 papers, 845 citations indexed

About

Katrin Tiemann is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Katrin Tiemann has authored 15 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Katrin Tiemann's work include RNA Interference and Gene Delivery (6 papers), CAR-T cell therapy research (4 papers) and MicroRNA in disease regulation (4 papers). Katrin Tiemann is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), CAR-T cell therapy research (4 papers) and MicroRNA in disease regulation (4 papers). Katrin Tiemann collaborates with scholars based in United States, Norway and United Kingdom. Katrin Tiemann's co-authors include John J. Rossi, John Burnett, Stephen J. Forman, Harris S. Soifer, Naira E. Souleimanian, Sijian Wang, Glen F. Deleavey, Masad J. Damha, Jessica Alluin and Pritsana Chomchan and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Katrin Tiemann

15 papers receiving 821 citations

Peers

Countries citing papers authored by Katrin Tiemann

Since Specialization

Citations

This map shows the geographic impact of Katrin Tiemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Tiemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Tiemann more than expected).

Fields of papers citing papers by Katrin Tiemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Tiemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Tiemann. The network helps show where Katrin Tiemann may publish in the future.

Co-authorship network of co-authors of Katrin Tiemann

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Tiemann. A scholar is included among the top collaborators of Katrin Tiemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Tiemann. Katrin Tiemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	PMB-CT01 (BAFFR-CAR T cell) therapy to examine preliminary safety and clinical responses in patients with B-cell malignancies who are ineligible for or failed CD19-directed therapy, including CD19-negative disease. 2024 ·Journal of Clinical Oncology ·Lihua E. Budde, (unknown), John H. Baird, Lu Chen, Joo Y. Song, Xiuli Wang, (unknown), (unknown), Teresa S. Kim, (unknown), (unknown), Min Guan, (unknown), Sandrine Puverel, Katrin Tiemann, Hazel Cheng, Stephen J. Forman, Larry W. Kwak, Ibrahim Aldoss	1
2	Promising Safety and Anti-Lymphoma Efficacy of Autologous Pmb-CT01 (BAFFRCAR T Cell) Therapy in a First-in-Human Phase 1 Study 2023 ·Blood ·Lihua E. Budde, (unknown), John H. Baird, Lu Chen, Joo Y. Song, (unknown), (unknown), Teresa S. Kim, (unknown), (unknown), Sandrine Puverel, Katrin Tiemann, (unknown), Stephen J. Forman, Larry W. Kwak	3
3	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis 2018 ·Oncogene ·Katrin Tiemann, Carolina Garri, Sang Bok Lee, Paymaneh D. Malihi, Min-Cheol Park, (unknown), (unknown), Parag Mallick, Jonathan E. Katz, Mitchell E. Gross, Kian Kani	28
4	Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays 2018 ·Journal of Visualized Experiments ·Katrin Tiemann, Carolina Garri, Jeffrey Wang, Lauren Clarke, Kian Kani	1
5	Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2) 2018 ·Oncotarget ·Carolina Garri, (unknown), Katrin Tiemann, Aleczandria S. Tiffany, Farzad Jalali‐Yazdi, (unknown), Jonathan E. Katz, Terry T. Takahashi, Ralf Landgraf, Mitchell E. Gross, Richard W. Roberts, Kian Kani	10
6	JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines 2017 ·Molecular Cancer Therapeutics ·Kian Kani, Carolina Garri, Katrin Tiemann, Paymaneh D. Malihi, Vasu Punj, (unknown), Janet Lee, Lindsey D. Hughes, (unknown), (unknown), (unknown), Jonathan E. Katz, David B. Agus, Parag Mallick	18
7	A Link between Integral Membrane Protein Expression and Simulated Integration Efficiency 2016 ·Cell Reports ·(unknown), Michiel J.M. Niesen, Axel Müller, Katrin Tiemann, Shyam M. Saladi, Rachel P. Galimidi, Bin Zhang, William Clemons, Thomas F. Miller	12
8	MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases 2013 ·RNA ·Sreenivas Chavali, Sören Bruhn, Katrin Tiemann, Pål Sætrom, Fredrik Barrenäs, Takaya Saito, Kartiek Kanduri, Hui Wang, Mikael Benson	34
9	Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells 2013 ·Nucleic Acids Research ·Jiehua Zhou, Katrin Tiemann, Pritsana Chomchan, Jessica Alluin, Piotr Swiderski, John Burnett, (unknown), Stephen J. Forman, Robert Chen, John J. Rossi	60
10	Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance 2012 ·Nucleic Acids Research ·Guillermo C. Rivera-Gonzalez, Alastair Droop, Helen J. Rippon, Katrin Tiemann, Davide Pellacani, (unknown), Norman J. Maitland	26
11	Antisense 2′-Deoxy, 2′-Fluoroarabino Nucleic Acid (2′F-ANA) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids 2012 ·Molecular Therapy — Nucleic Acids ·Naira E. Souleimanian, Glen F. Deleavey, Harris S. Soifer, Sijian Wang, Katrin Tiemann, Masad J. Damha, Cy A. Stein	55
12	Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines 2011 ·Leukemia & lymphoma ·Katrin Tiemann, Jessica Alluin, Anja Honegger, Pritsana Chomchan, Shikha Gaur, Yun Yen, Stephen J. Forman, John J. Rossi, Robert W. Chen	14
13	Current progress of siRNA/shRNA therapeutics in clinical trials 2011 ·Biotechnology Journal ·John Burnett, John J. Rossi, Katrin Tiemann	353
14	Dual-targeting siRNAs 2010 ·RNA ·Katrin Tiemann, (unknown), Ali A. Ehsani, Stephen J. Forman, John J. Rossi, Pål Sætrom	17
15	RNAi‐based therapeutics–current status, challenges and prospects 2009 ·EMBO Molecular Medicine ·Katrin Tiemann, John J. Rossi	213

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact